Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
5.61
-0.34 (-5.71%)
Apr 14, 2026, 2:33 PM AST

TADAWUL:9626 Cash Flow Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Net Income
7.36.34.873.78
Depreciation & Amortization
2.711.251.170.77
Loss (Gain) From Sale of Assets
-0.04---
Other Operating Activities
1.310.740.340.28
Change in Accounts Receivable
----0.08
Change in Inventory
0.01-0.59-0.47-0.12
Change in Accounts Payable
0.63-0.09-0.432.41
Change in Other Net Operating Assets
-0.570.37-0.27-
Operating Cash Flow
11.377.985.217.04
Operating Cash Flow Growth
42.49%53.17%-26.01%-
Capital Expenditures
-6.61-1.32-1.14-1.8
Sale of Property, Plant & Equipment
0.05---
Investing Cash Flow
-6.56-1.32-1.14-1.8
Long-Term Debt Repaid
-2.04-1.23-1.11-0.63
Net Debt Issued (Repaid)
-2.04-1.23-1.11-0.63
Issuance of Common Stock
16.536.5--
Common Dividends Paid
----3.6
Financing Cash Flow
14.55.27-1.11-4.23
Net Cash Flow
19.311.932.961.01
Free Cash Flow
4.766.664.075.24
Free Cash Flow Growth
-28.52%63.68%-22.33%-
Free Cash Flow Margin
10.47%19.64%15.34%23.90%
Free Cash Flow Per Share
0.260.580.43-
Levered Free Cash Flow
1.194.12.21-
Unlevered Free Cash Flow
1.664.312.44-
Change in Working Capital
0.08-0.31-1.172.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.